CPT® Code 19105

1. Indications

The procedure described by CPT® Code 19105 is indicated for the treatment of fibroadenomas in the breast. The following conditions may warrant the use of cryosurgical ablation:

• Palpable Fibroadenoma - A fibroadenoma that can be felt during a physical examination.
• Mammographic Abnormality - A fibroadenoma that is detected through imaging studies, such as a mammogram, but is not necessarily palpable.

2. Procedure

The cryosurgical ablation procedure involves several key steps to ensure effective treatment of the fibroadenoma:

• Step 1: Ultrasound Guidance - The procedure begins with the use of ultrasound imaging to accurately locate the fibroadenoma within the breast tissue. This imaging technique allows the physician to visualize the tumor and plan the approach for the ablation.
• Step 2: Probe Insertion - Once the fibroadenoma is identified, a specialized cryoablation probe is carefully inserted into the tumor mass. The probe is designed to deliver the necessary cooling agent directly to the target tissue.
• Step 3: Cryoablation - The probe typically contains liquid nitrogen, which is utilized to cool the tissue to temperatures below -20 degrees Celsius. This extreme cold is maintained for a specific duration to ensure effective ablation of the fibroadenoma.
• Step 4: Monitoring - Throughout the procedure, the physician monitors the treatment area using ultrasound to ensure that the ablation is proceeding as planned and to assess the response of the tissue.
• Step 5: Completion - After the appropriate cooling time, the probe is removed, and the procedure is concluded. The area may be assessed for any immediate complications or concerns.

3. Post-Procedure

Following the cryosurgical ablation of a fibroadenoma, patients may experience some localized swelling or discomfort at the treatment site. It is important for healthcare providers to monitor the patient for any signs of complications. Patients are typically advised on post-procedure care, which may include recommendations for pain management and activity restrictions. Follow-up appointments may be scheduled to evaluate the treatment's effectiveness and to ensure proper healing of the breast tissue.